Successful Treatment of Nocardia nova Bacteremia and Multilobar Pneumonia With Clarithromycin in a Heart Transplant Patient

Transplantation Proceedings

Volumn 39, Issue 5, 2007, Pages 1720-1722

  Naik, S ^a   Mateo Bibeau, R ^b   Shinnar, M ^a   Mahal, M ^b   Freudenberger, R ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Immunology and Infectious Diseases

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CASPOFUNGIN; CEFOTAXIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; LINEZOLID; METRONIDAZOLE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TOBRAMYCIN; VANCOMYCIN;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LOADING DRUG DOSE; LOBAR PNEUMONIA; MALE; NOCARDIA; NOCARDIA NOVA; NOCARDIOSIS; PRIORITY JOURNAL;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CLARITHROMYCIN; HEART TRANSPLANTATION; HUMANS; LUNG DISEASES; MALE; NOCARDIA INFECTIONS; PNEUMONIA; POSTOPERATIVE COMPLICATIONS;

EID: 34250198948     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.11.029     Document Type: Article

References (13)

1. Fishman J.A., and Rubin R.H. Infection in organ-transplant recipients. N Eng J Med 338 (1998) 1741
2. Beaman B.L., Burnside J., Edwards B., et al. Nocardial infections in the United States, 1972-1974. J Infect Dis 134 (1976) 286
3. Peraira J.R., Segovia J., Fuertes B., et al. Current induction immunosuppression and post-heart transplant lymphoproliferative disorders. Transplant Proc 35 (2003) 2009
4. Tripodi M.F., Adinolfi L.E., Andreana A., et al. Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies. Clin Transplant 15 (2001) 415
5. Roberts S.A., Franklin J.C., Mijch A., et al. Nocardia infection in heart-lung transplant recipients at Alfred Hospital, Melbourne, Australia, 1989-1998. Clin Infect Dis 31 (2000) 968
6. Hofflin J.M., Potasman I., Baldwin J.C., et al. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 106 (1987) 209
7. Simpson G.L., Stinson E.B., Egger M.J., et al. Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis 3 (1981) 492
8. Saubolle M.A., and Sussland D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol 41 (2003) 4497
9. Maderazo E.G., and Quintiliani R. Treatment of nocardial infection with trimethoprim and sulfamethoxazole. Am J Med 57 (1974) 671
10. Wallace Jr. R.J., and Steele L.C. Susceptibility testing of Nocardia species for the clinical laboratory. Diagn Microbiol Infect Dis 9 (1988) 155
11. Geiseler P.J., Check F., Lamothe F., et al. Failure of trimethoprim/sulfamethoxazole in invasive Nocardia asteroides infection. Arch Intern Med 139 (1979) 355
12. Gombert M.E. Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin. Antimicrob Agents Chemother 21 (1982) 1011
13. Wallace Jr. R.J., Brown B.A., Tsukamura M., et al. Clinical and laboratory features of Nocardia nova. J Clin Microbiol 29 (1991) 2407